Mohsen Paulash 4
4 · YUMANITY THERAPEUTICS, INC. · Filed Dec 3, 2021
Insider Transaction Report
Form 4
Mohsen Paulash
Chief Business Officer
Transactions
- Award
Common Stock
2021-12-01+20,000→ 61,093 total
Footnotes (1)
- [F1]Restricted stock award granted under the Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan. Fifty percent of the shares subject to the award will vest six months after the grant date and fifty percent will vest twelve months after the grant date, provided that the award recipient continues to have a service relationship with the Company at such time.